VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 234 filers reported holding VERACYTE INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $465,367 | +4.1% | 20,844 | +18.8% | 0.00% | 0.0% |
Q2 2023 | $446,865 | +15.4% | 17,551 | +1.0% | 0.00% | 0.0% |
Q1 2023 | $387,331 | -3.6% | 17,380 | +2.5% | 0.00% | 0.0% |
Q4 2022 | $401,810 | +148.0% | 16,954 | +74.0% | 0.00% | – |
Q3 2022 | $162,000 | +11.7% | 9,745 | +33.6% | 0.00% | – |
Q2 2022 | $145,000 | -12.7% | 7,295 | +14.1% | 0.00% | – |
Q1 2022 | $166,000 | -34.1% | 6,396 | +5.0% | 0.00% | – |
Q4 2021 | $252,000 | +8.2% | 6,092 | +21.8% | 0.00% | – |
Q3 2021 | $233,000 | +48.4% | 5,002 | +27.6% | 0.00% | – |
Q2 2021 | $157,000 | +48.1% | 3,919 | +100.9% | 0.00% | – |
Q1 2021 | $106,000 | -5.4% | 1,951 | -15.4% | 0.00% | – |
Q4 2020 | $112,000 | -77.6% | 2,307 | -85.0% | 0.00% | -100.0% |
Q3 2020 | $499,000 | +508.5% | 15,341 | +384.4% | 0.00% | – |
Q2 2020 | $82,000 | +60.8% | 3,167 | +51.5% | 0.00% | – |
Q1 2020 | $51,000 | – | 2,090 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |